K181498 is an FDA 510(k) clearance for the X-ray Imaging System for the McLaren Proton Treatment System. Classified as System, Radiation Therapy, Charged-particle, Medical (product code LHN), Class II - Special Controls.
Submitted by Ehmetdx, LLC (Plymouth, US). The FDA issued a Cleared decision on December 10, 2018 after a review of 186 days - an extended review cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.